Matrix Biology Plus (Dec 2023)

Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development

  • Athiramol Sasi,
  • Andreas Romaine,
  • Pugazendhi Murugan Erusappan,
  • Arne Olav Melleby,
  • Almira Hasic,
  • Christen Peder Dahl,
  • Kaspar Broch,
  • Vibeke Marie Almaas,
  • Rosa Doñate Puertas,
  • H. Llewelyn Roderick,
  • Ida Gjervold Lunde,
  • Ivar Sjaastad,
  • Maria Vistnes,
  • Geir Christensen

Journal volume & issue
Vol. 19
p. 100135

Abstract

Read online

Cardiac fibrosis is a central pathological feature in several cardiac diseases, but the underlying molecular players are insufficiently understood. The extracellular matrix proteoglycan versican is elevated in heart failure and suggested to be a target for treatment. However, the temporal expression and spatial distribution of versican and the versican cleavage fragment containing the neoepitope DPEAAE in cardiac fibrosis remains to be elucidated. In this study, we have examined versican during cardiac fibrosis development in a murine pressure overload model and in patients with cardiomyopathies. We found that versican, mainly the V1 isoform, was expressed immediately after induction of pressure overload, preceding collagen accumulation, and versican protein levels extended from the perivascular region into the cardiac interstitium. In addition, we found increased production of versican by collagen expressing fibroblasts, and that it was deposited extensively in the fibrotic extracellular matrix during pressure overload. In cardiac cell cultures, the expression of versican was induced by the pro-fibrotic transforming growth factor beta and mechanical stretch. Furthermore, we observed that the proteolytic cleavage of versican (DPEAAE fragment) increased in the late phase of fibrosis development during pressure overload. In patients with hypertrophic and dilated cardiomyopathies, we found elevated levels of versican and a positive correlation between versican and collagen mRNA in the heart, as well as increased cleavage of full-length protein. Taken together, the temporal expression profile and the spatial distribution of both the full-length versican and the DPEAAE fragment observed in this study indicates a role for versican in development of cardiac fibrosis.

Keywords